Theriva Biologics, Inc. (TOVX)
0.24
0.00 (0.00%)
USD |
NYAM |
Aug 24, 16:00
0.24
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Shareholders Equity (Quarterly) : 12.19M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.19M |
| March 31, 2026 | 15.40M |
| December 31, 2025 | 15.38M |
| September 30, 2025 | 6.738M |
| June 30, 2025 | 10.62M |
| March 31, 2025 | 15.50M |
| December 31, 2024 | 19.07M |
| September 30, 2024 | 24.64M |
| June 30, 2024 | 27.65M |
| March 31, 2024 | 34.12M |
| December 31, 2023 | 39.70M |
| September 30, 2023 | 43.88M |
| June 30, 2023 | 47.75M |
| March 31, 2023 | 50.59M |
| December 31, 2022 | 54.56M |
| September 30, 2022 | 58.15M |
| June 30, 2022 | 61.67M |
| March 31, 2022 | 68.03M |
| December 31, 2021 | 65.41M |
| September 30, 2021 | 73.33M |
| June 30, 2021 | 76.50M |
| March 31, 2021 | 79.60M |
| December 31, 2020 | 8.031M |
| September 30, 2020 | 6.682M |
| June 30, 2020 | 8.703M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.48M |
| December 31, 2019 | 14.36M |
| September 30, 2019 | 17.41M |
| June 30, 2019 | 22.44M |
| March 31, 2019 | 25.88M |
| December 31, 2018 | 29.36M |
| September 30, 2018 | 8.501M |
| June 30, 2018 | 5.686M |
| March 31, 2018 | 8.926M |
| December 31, 2017 | 10.56M |
| September 30, 2017 | 7.204M |
| June 30, 2017 | 4.83M |
| March 31, 2017 | 2.569M |
| December 31, 2016 | 3.845M |
| September 30, 2016 | -4.476M |
| June 30, 2016 | 2.294M |
| March 31, 2016 | 6.258M |
| December 31, 2015 | 16.05M |
| September 30, 2015 | 25.87M |
| June 30, 2015 | -13.66M |
| March 31, 2015 | -1.625M |
| December 31, 2014 | 9.556M |
| September 30, 2014 | 3.757M |
| June 30, 2014 | 8.057M |
| March 31, 2014 | 11.76M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | -161.84M |
| Nkarta, Inc. | 247.74M |
| Unicycive Therapeutics, Inc. | 53.27M |
| OnKure Therapeutics, Inc. | 172.11M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 34.86M |
| Total Liabilities (Quarterly) | 22.67M |
| Debt to Equity Ratio | 0.2915 |
| Current Ratio | 1.129 |
| Net Debt Paydown Yield | -1.22% |